Human medicines European public assessment report (EPAR): Pedmarqsi, sodium thiosulfate, Ear Diseases;Ototoxicity, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Multiple Myeloma, Date of authorisation: 25/08/2020, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Norvir, ritonavir, HIV Infections, Date of authorisation: 25/08/1996, Revision: 69, Status: Authorised
Herbal medicinal product: Ginseng radix, Ginseng radix, F: Assessment finalised
Management Board meeting: 5 October 2023, European Medicines Agency, Amsterdam, the Netherlands, from 05/10/2023 to 05/10/2023
Minutes – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG)
EMA takes further steps to address critical shortages of medicines in the EU
MSSG Solidarity Mechanism
MSSG Toolkit on recommendations on tackling shortages of medicinal products
Human medicines European public assessment report (EPAR): Actelsar HCT, telmisartan,hydrochlorothiazide, Essential Hypertension, Date of authorisation: 13/03/2013, Revision: 17, Status: Authorised